Individuals who are pregnant, planning pregnancy or breastfeeding should discuss treatment options with a qualified healthcare professional before starting GLP-1 therapy
The research team, led by first author Maria Ukhanova, MD, PhD, assistant professor in the Department of Management, Policy and Community Health, and the Center for Health Care Data at the School of Public Health, analyzed claims data of over 28 million national members from the Merative Marketscan Research Databases
GLP-1 medications can produce substantial weight loss
Spinal and paraspinal plexiform neurofibromas in patients with neurofibromatosis type 1: a novel scoring system for radiological-clinical correlation
If it is almost time for your next dose, take only that dose
The buzz around BPC-157 stems from its reputation as a powerful healing agent